Accession Number: | 0001209191-22-054725 |
Date: | 2022-10-26 |
Issuer: | THIRD HARMONIC BIO, INC. (THRD) |
Original Submission Date: |
GLADSTONE MICHAEL
C/O THIRD HARMONIC BIO, INC.
300 TECHNOLOGY SQUARE, 8TH FLOOR
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 17.83 | 2022-10-26 | deemed execution date | A | 13,667 (a) | 2032-10-25 | common stock 13,667 | $17.83 | 13,667 | direct |
ID | footnote |
---|---|
f1 | the option vests over a 8-month period: 1/8th on october 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date. |
f2 | the reporting person is a member of atlas venture life science advisors, llc ("atlas") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to atlas. as such, the reporting person disclaims beneficial ownership of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, except to the extent of his pecuniary interest therein, if any. |